Skip to main content
An official website of the United States government
Email

Dr. Xu Zhang provides scientific expertise in Proteomics Data Science/Data Management, manages and oversees the grants and contracts that support proteomics data analysis, informatics and software tools, and data management activities for several Office of Cancer Clinical Proteomics Research (OCCPR) supported programs, including the Clinical Proteomic Tumor Analysis Consortium (CPTAC), International Cancer Proteogenome Consortium (ICPC), and the Applied Proteogenomics Organizational Learning and Outcomes (APOLLO) network. Dr. Zhang also supports NCI’s Proteome Characterization Laboratory at the Frederick National Laboratory for Cancer Research.

Dr. Zhang joined the DCTD in 2021 as a Program Manager for OCCPR. Prior to joining OCCPR, Dr. Zhang was a scientist within the Collaborative Protein Technology Resource at the NCI’s Center for Cancer Research (CCR). Dr. Zhang in this role, collaborated with CCR researchers to further investigate critical biological questions in their research through the use of mass spectrometry and proteomic data analysis. She has led and managed multiple intramural proteogenomic projects of studying tumor heterogeneity, identifying new targets for drug resistance, and developing MS-based quantitative assay for clinical cancer research of lung adenocarcinoma. Dr. Zhang has extensive experience in the proteogenomic field, especially in proteomics data management.

Education

  • Ph.D., Analytical Chemistry, University of Wisconsin-Madison, Madison, WI
  • M.S., Inorganic Chemistry, Peking University, Beijing, China
  • B.S., Chemistry, Peking University, Beijing, China
Email